BIMI International Medical Inc. (BIMI) Financial Statements (2023 and earlier)
Company Profile
| Business Address |
725 5TH AVENUE, 15TH FLOOR, 15-01 NEW YORK, NY NEW YORK |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 5122 - Drugs, Drug Proprietaries, and Druggists' Sundries (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 3/31/2023 MRQ | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 2,337 | 4,798 | 135 | 36 | 18 | 282 | |||
| Cash and cash equivalents | 2,337 | 4,798 | 135 | 36 | 18 | 282 | |||
| Receivables | 3,208 | 7,602 | 6,687 | 86 | 1,341 | 12,281 | |||
| Inventory, net of allowances, customer advances and progress billings | 7,654 | 2,640 | 735 | 708 | 938 | 2,064 | |||
| Inventory | 7,654 | 2,640 | 735 | 708 | 938 | 2,064 | |||
| Prepaid expense | 6,646 | 294 | 187 | ||||||
| Deferred costs | (70,144) | 1,228 | |||||||
| Disposal group, including discontinued operation | 21,219 | ||||||||
| Other undisclosed current assets | 73,534 | 4,598 | 17,627 | 2 | 311 | 3,942 | |||
| Total current assets: | 23,236 | 21,160 | 25,184 | 22,050 | 2,607 | 18,756 | |||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 2,942 | 4,846 | ✕ | ✕ | |||||
| Property, plant and equipment | 1,703 | 3,521 | 910 | 17,958 | 19,987 | ||||
| Long-term investments and receivables | 1,800 | ||||||||
| Long-term investments | 1,800 | ||||||||
| Intangible assets, net (including goodwill) | 2,082 | 8,394 | 6,914 | 7,973 | 2,461 | 2,664 | |||
| Goodwill | 2,066 | 8,376 | 6,914 | ||||||
| Intangible assets, net (excluding goodwill) | 16 | 18 | 7,973 | 2,461 | 2,664 | ||||
| Deferred income tax assets | 190 | 208 | 193 | ✕ | ✕ | ||||
| Other undisclosed noncurrent assets | 3,761 | 39 | 25 | 26 | |||||
| Total noncurrent assets: | 12,479 | 16,969 | 8,018 | 8,012 | 20,444 | 22,677 | |||
| TOTAL ASSETS: | 35,714 | 38,128 | 33,202 | 30,062 | 23,051 | 41,433 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 12,993 | 8,665 | 7,681 | 104 | 750 | 3,976 | |||
| Taxes payable | ✕ | ✕ | 663 | 774 | 1 | ||||
| Employee-related liabilities | ✕ | ✕ | 754 | ||||||
| Accounts payable | 10,786 | 7,339 | 5,852 | 104 | 750 | 3,976 | |||
| Accrued liabilities | 2,207 | 663 | 301 | ||||||
| Debt | 924 | 2,169 | 938 | 5,817 | 7,224 | ||||
| Disposal group, including discontinued operation | 13,108 | ||||||||
| Due to related parties | 4,600 | 730 | 227 | 306 | 918 | 432 | |||
| Customer advances and deposits | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | 513 | ||
| Other liabilities | 630 | 954 | 4 | 983 | 857 | ||||
| Other undisclosed current liabilities | 6,215 | 9,575 | 6,719 | 8,027 | 4,597 | 1,134 | |||
| Total current liabilities: | 25,362 | 22,092 | 15,565 | 21,549 | 13,065 | 14,136 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 315 | 4,700 | 743 | ||||||
| Long-term debt, excluding current maturities | 315 | 538 | 721 | ||||||
| Liabilities, other than long-term debt | 2,575 | ||||||||
| Operating lease, liability | 2,575 | 4,162 | 22 | ✕ | ✕ | ||||
| Other undisclosed noncurrent liabilities | 2,245 | (4,162) | (22) | ||||||
| Total noncurrent liabilities: | 5,135 | 4,700 | 743 | ||||||
| Total liabilities: | 30,497 | 26,792 | 16,309 | 21,549 | 13,065 | 14,136 | |||
| Equity | |||||||||
| Equity, attributable to parent, including: | 4,048 | 11,193 | 16,710 | 8,683 | 10,136 | 27,248 | |||
| Common stock | 4 | 9 | 13 | 9 | 8 | 7 | |||
| Additional paid in capital | 71,899 | 55,220 | 26,345 | 15,644 | 12,555 | 12,056 | |||
| Accumulated other comprehensive income (loss) | 25 | 1,602 | 1,003 | 1,684 | 1,788 | 2,614 | |||
| Retained earnings (accumulated deficit) | (70,144) | 12,571 | |||||||
| Other undisclosed equity, attributable to parent | 2,264 | (45,637) | (10,651) | (8,654) | (4,215) | ||||
| Equity, attributable to noncontrolling interest | 1,170 | 143 | 183 | (170) | (150) | 49 | |||
| Total equity: | 5,217 | 11,336 | 16,893 | 8,513 | 9,985 | 27,297 | |||
| TOTAL LIABILITIES AND EQUITY: | 35,714 | 38,128 | 33,202 | 30,062 | 23,051 | 41,433 | |||
Income Statement (P&L) ($ in thousands)
| 3/31/2023 TTM | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 11,830 | 27,080 | 12,845 | 158 | 8,508 | |||
| Revenue, net | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | 8,508 | |
| Other operating income | 22,393 | 8,107 | ||||||
| Cost of revenue | (9,880) | (22,483) | (10,402) | (304) | (6,083) | (7,592) | ||
| Cost of goods and services sold | (60) | (94) | (7,592) | |||||
| Other undisclosed gross profit | 6,542 | |||||||
| Gross profit: | 1,950 | 4,596 | 2,443 | (146) | 459 | 917 | ||
| Operating expenses | (17,288) | (36,854) | (6,255) | (1,567) | (16,253) | (2,112) | ||
| Operating loss: | (15,338) | (32,258) | (3,812) | (1,713) | (15,794) | (1,195) | ||
| Nonoperating income (expense) | (6,284) | (2,645) | 461 | (556) | (1,206) | (381) | ||
| Investment income, nonoperating | (3,260) | (1,974) | ||||||
| Gain (loss), foreign currency transaction, before tax | (7) | 25 | 547 | |||||
| Other nonoperating expense | (2,847) | (344) | (2) | (550) | (790) | (27) | ||
| Interest and debt expense | (170) | (351) | (85) | (6) | (416) | (354) | ||
| Other undisclosed income from continuing operations before equity method investments, income taxes | 85 | 6 | 416 | 354 | ||||
| Loss from continuing operations before equity method investments, income taxes: | (21,793) | (35,253) | (3,352) | (2,269) | (17,000) | (1,576) | ||
| Other undisclosed income from continuing operations before income taxes | 170 | 351 | ||||||
| Loss from continuing operations before income taxes: | (21,622) | (34,902) | (3,352) | (2,269) | (17,000) | (1,576) | ||
| Income tax expense (benefit) | (6) | (19) | (434) | (0) | (3) | |||
| Loss from continuing operations: | (21,628) | (34,922) | (3,786) | (2,269) | (17,000) | (1,578) | ||
| Loss before gain (loss) on sale of properties: | ✕ | (34,922) | (1,878) | (4,452) | (17,000) | (1,578) | ||
| Income (loss) from discontinued operations | (41) | 1,908 | (2,183) | |||||
| Other undisclosed net loss | (649) | |||||||
| Net loss: | (22,318) | (34,922) | (1,878) | (4,452) | (17,000) | (1,578) | ||
| Net income (loss) attributable to noncontrolling interest | (75) | (64) | 14 | 213 | 9 | |||
| Other undisclosed net loss attributable to parent | (119) | |||||||
| Net loss attributable to parent: | (22,393) | (34,986) | (1,997) | (4,439) | (16,787) | (1,570) | ||
| Other undisclosed net income available to common stockholders, basic | 64 | 119 | ||||||
| Net loss available to common stockholders, basic: | (22,393) | (34,922) | (1,878) | (4,439) | (16,787) | (1,570) | ||
| Other undisclosed net income available to common stockholders, diluted | 75 | |||||||
| Net loss available to common stockholders, diluted: | (22,318) | (34,922) | (1,878) | (4,439) | (16,787) | (1,570) | ||
Comprehensive Income ($ in thousands)
| 3/31/2023 TTM | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (22,318) | (34,922) | (1,878) | (4,452) | (17,000) | (1,578) | ||
| Other comprehensive income (loss) | (3,874) | 1,757 | ||||||
| Other undisclosed comprehensive income (loss) | 2,297 | (942) | (111) | (826) | ||||
| Comprehensive income (loss): | (23,895) | (34,922) | (2,820) | (4,563) | (17,825) | 178 | ||
| Comprehensive income, net of tax, attributable to noncontrolling interest | 1,053 | 26 | 17 | 20 | 213 | 7 | ||
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | 598 | |||||||
| Comprehensive income (loss), net of tax, attributable to parent: | (22,843) | (34,297) | (2,803) | (4,543) | (17,612) | 186 | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.